16 IMAGING OF CARTILAGE - CHANGE IN PARADIGMS  by Link, Thomas
Osteoarthritis and Cartilage Vol. 14, Supplement B S7
15
CARTILAGE INTERSTITIAL FLUID PRESSURIZATION IS
FAR MORE EFFECTIVE AT REDUCING FRICTION THAN
BOUNDARY LUBRICATION BY SYNOVIAL FLUID
Gerard Ateshian
Purpose: Many studies have reported that synovial fluid (SF)
acts as an effective boundary lubricant in diarthrodial joints,
reducing the friction coefficient at the articular surfaces. Sev-
eral treatment modalities aim to reproduce the beneficial role
of SF, by identifying the major constituent responsible for its
tribological properties, such as hyaluronic acid, lubricin, or phos-
pholipids. Another mechanism which is effective in reducing the
friction of articular cartilage is the natural pressurization of its
interstitial fluid upon loading, which helps support most of the
joint contact load and reduce the frictional force acting on the
collagen-proteoglycan matrix. The specific aim of this study was
to characterize which of these two mechanisms is more effective.
Methods: In Experiment 1, 12 medial and lateral tibio-femoral
joint pairs from 6 fresh immature bovine joints were tested in a
custom friction apparatus. A constant load of 6.3 N was applied
on the condyle while the tibial plateau was translated ±10 mm
at 1 mm/s for a total test duration of 15 minutes. Six joints were
tested with phosphate buffered saline (PBS) as the lubricant and
the other six with bovine SF, collected from 5 adult bovine wrist
joints. The friction coefficient was measured as a function of
time. The initial (μ0), minimum (μmin) and final (μf) values in PBS
and SF were compared statistically using a two-way ANOVA. In
Experiment 2, a ♦4 mm chondral plug was harvested from the
tibial plateau of joints tested in Experiment 1 to perform friction
measurements against a glass slide, under a constant load of
6.3 N, translating ±4.5 mm at 1 mm/s for 2 hours. Each plug was
tested in the same lubricant used with the corresponding joint.
The minimum (μmin) and equilibrium (μeq) friction coefficients in
PBS and SF were similarly compared statistically.
Results: In Experiment 1, the friction coefficient was found to
remain nearly constant over the entire test for both lubricants
(Table 1), with no differences found between μ0, μmin and μf
(p=0.80). The friction coefficient in SF was significantly smaller
than in PBS (p=0.013). In Experiment 2 the friction coefficient
rose significantly with time, as shown in the mean and standard
deviation responses over all specimens in Fig. 1. μmin was
considerably smaller than μeq for both lubricants (p<0.0001).




μ0 0.023±0.008 0.017±0.004* 1.5
μmin 0.021±0.009 0.014±0.008* 1.3
μf 0.022±0.009 0.015±0.003* 1.5
Experiment 2
μmin 0.0027±0.0011 0.0015±0.0003*† 1.8
μeq 0.155±0.017 0.088±0.008*† 1.8
μeq/μmin 57 59
*p<0.05, SF vs PBS. †p<0.05, μeq vs μmin.
Fig. 1. Experiment 2.
Conclusions: The transient frictional response observed in Ex-
periment 2 (Fig. 1) has been shown to correlate with the mag-
nitude of interstitial fluid pressurization in our previous studies.
μmin is achieved immediately upon loading, when the pressure
is greatest; μeq is achieved after a prolonged duration, when the
pressure has subsided. Therefore, the ratio μeq/μmin represents
the effectiveness of interstitial fluid pressurization in reducing fric-
tion. Conversely, the effectiveness of synovial fluid as a boundary
lubricant can be assessed from the ratio (μPBS)/(μSF), equally
applicable for μ0, μmin, μf and μeq. As seen in the last column
and last row of Table 1, SF reduces the friction coefficient by
a factor of 2 at most, whereas interstitial fluid pressurization
reduces it by a factor of nearly 60. Therefore, cartilage interstitial
fluid pressurization is far more effective at reducing friction than
boundary lubrication by synovial fluid.
While the configuration of Experiment 2 is ideal for assessing
the effectiveness of interstitial fluid pressurization, it is not repre-
sentative of physiological loading conditions since it produces an
elevated, potentially detrimental friction coefficient under equi-
librium conditions, when the fluid pressure has subsided. In
contrast, Experiment 1 shows that under physiological loading
conditions, where natural cartilage surfaces slide against each
other with migrating contact areas, there is no loss of intersti-
tial fluid pressurization and the friction coefficient remains low
for prolonged loading durations. Either experiment is able to
demonstrate the effectiveness of SF as a boundary lubricant, by
comparing SF to PBS; however, only Experiment 2 can demon-
strate the effectiveness of interstitial fluid pressurization.
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IMAGING OF CARTILAGE - CHANGE IN PARADIGMS
Thomas Link
In the last decade therapeutic management of cartilage injury
and degeneration has changed substantially. Currently cartilage
repair techniques and pharmacological therapies are areas of
major clinical interest and research, in particular to prevent
and treat osteoarthritis. Given these advancements adequate
diagnostic techniques are required to better assess outcome
of new therapies and to tailor therapies for individual patients.
Radiographs are limited and MRI clearly has been shown to
provide superior information concerning cartilage, the underlying
bone and internal structures of the joints, including ligaments
and menisci.
Traditionally morphologic, pathological cartilage changes in MR
images have been described and defects have been classified
semi quantitatively, as lesions with more or less than 50% loss
or full thickness lesions. Visualization of these cartilage lesions
has been substantially improved (i) with dedicated cartilages
sequences, such as proton density-weighted fast spin echo,
spoiled gradient echo and dual echo steady state sequences, and
(ii) with the event of clinical 3.0T high field MRI. New sequences
are also currently studied to optimize cartilage imaging, which
include driven equilibrium Fourier transform and steady-state
free precession based imaging.
Since these techniques may be of limited value to study early
disease and may have limitations in the assessment of disease
progression quantitative techniques have been established to de-
termine cartilage volume. These techniques may be particularly
useful to study the significance of new pharmacological cartilage
protective therapies.
New developments now aim at quantifying pathological changes
of the cartilage matrix before damage of the tissue is morpho-
logically evident. Since cartilage loss is irreversible these new
techniques would allow to diagnose and potentially treat early de-
generation at a stage when the cartilage surface is still intact and
changes may be reversible. The most widely applied techniques
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to study cartilage matrix are currently (i) dGEMRIC (delayed
gadolinium enhanced magnetic resonance imaging of cartilage),
(ii) T2 relaxation time measurements and (iii) T1rho mapping
techniques. These techniques have shown merit in determining
the amount of macromolecules, such as glycosaminoglycans,
within the cartilage and quantifying its water content.
In summary MRI’s role in cartilage imaging is evolving with new
diagnostic requirements; while assessment of cartilage morphol-
ogy is still standard, innovative techniques to quantify matrix
changes at early stages will be increasingly important in the
future to tailor therapies and better understand disease progres-
sion on a molecular level.
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NOVEL MEDIATORS OF CHONDROCYTE GENE
EXPRESSION IN DEVELOPMENT AND OSTEOARTHRITIS
Mary B. Goldring
The human adult articular chondrocyte is a unique cell type
that has reached a terminally differentiated state within the car-
tilage matrix as an end-point of development. In cartilage of
patients with osteoarthritis (OA), the chondrocytes may undergo
phenotypic modulation in response to alterations in the environ-
ment due to the mechanical loading and inflammation. Isolated
chondrocytes in primary culture have provided useful models
to study cellular responses to alterations in the environment
such as those occurring in different forms of arthritis [1]. Immor-
talized chondrocytes of human origin have been developed to
serve as reproducible models for studying transcriptional regu-
lation of chondrocyte function by inflammatory mediators such
as interleukin-1β (IL-1β) [2]. We reported previously that activa-
tion of EGR-1 by IL-1β results in early, transient suppression of
proximal COL2A1 promoter activity by displacement of Sp1 from
GC boxes [3]. The epithelium-specific ETS (ESE)-1 is expressed
predominantly in epithelial cells but can also be induced in other
cell types including chondrocytes in response to inflammatory
mediators such as IL-1β and upregulates IL-1-induced genes,
including COX-2 [4,5]. ESE-1 is a potent transcriptional suppres-
sor of COL2A1 promoter activity in chondrocytes, accounting
for the sustained, NF-κB-dependent inhibition by IL-1β, and acts
by interfering with the activator functions of CBP/300 and Sox9
[6]. Our finding that ESE-1 protein is localized intracellularly in
chondrocytes in cartilage from patients with osteoarthritis but
not from individuals with normal joints and that IL-1β induces
ESE-1 expression in adult human articular chondrocytes further
suggest a fundamental role for ESE-1 in cartilage degeneration
and suppression of repair.
Recently, we have identified novel pathways that regulate chon-
drocyte terminal differentiation in the growth plate during endo-
chondral ossification and also modulate chondrocyte phenotype
in osteoarthritis. A microarray study of BMP-2-induced genes
resulted in the discovery of a novel role for growth arrest and
DNA damage inducible (GADD) 45β in chondrocyte survival and
up-regulation of MMP-13 and Col10a1 gene expression during
chondrogenesis [7,8]. The GADD45β gene product is implicated
in the stress response, cell cycle arrest and apoptosis. GADD45α
and γ, which are important mediators of tumor cell apoptosis,
are not upregulated by BMP-2. In recent studies, we have begun
to investigate the relative contributions of ESE-1 and GADD45β
to OA initiation and progression, since both factors up-regulate
MMP-13 gene expression and are expressed in early OA car-
tilage and at 3 to 6 months in the cho/+ mouse model, which
develops OA-like pathology due to mutations that disrupt the
collagen network [9]. We have also asked whether similar mech-
anisms regulate chondrocyte hypertrophy both during remod-
eling of the calcified cartilage matrix of the hypertrophic zone
of the growth plate and during tidemark advancement in OA.
Both processes share the features of chondrocyte hypertrophy,
apoptosis and MMP-13-mediated remodeling. The distribution
of immunostaining for GADD45β in early OA cartilage at sites
peripheral to the lesion in chondrocyte clusters and in deep zone
chondrocytes, along with our finding that it suppresses apop-
tosis, suggests that GADD45β may serve as a survival factor
in activated chondrocytes, while promoting hypertrophy during
tidemark advancement. An understanding of the relative contri-
butions of the GADD45β and ESE-1 pathways to physiological
cartilage homeostasis will provide understanding of the molecular
mechanisms responsible for dysregulated cartilage remodeling
in joint disease.
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GENETIC INFLUENCES ON OSTEOARTHRITIS: AN
UPDATE
Tim D. Spector
A number of studies in the last few years have shown unequiv-
ocal evidence that at least 50% of the variance of OA in the
hands, knees and hips is accounted for by genetic factors. These
include classical twin studies of unselected populations as well
as population based family studies and affected sib pair studies.
A genetic effect on spinal disk degeneration, and spinal osteo-
phytes, has also been demonstrated in twins using MRI data.
